Description
NSE notification for listing of 1,398,463 equity shares of Kilitch Drugs (India) Limited allotted under rights issue, effective August 28, 2025.
Summary
NSE has notified the listing of additional equity shares of Kilitch Drugs (India) Limited issued under a rights issue. The shares will be admitted to trading on the Capital Market segment with effect from August 28, 2025.
Key Points
- Company: Kilitch Drugs (India) Limited (Symbol: KILITCH)
- Number of shares: 1,398,463 equity shares
- Face value: Rs. 10 per share
- Issue price: Rs. 357 per share
- Date of allotment: August 25, 2025
- ISIN: INE729D01010
- Market lot: 1 share
- Distinctive number range: 16082320 to 17480782
Regulatory Changes
No regulatory changes introduced. This is a routine listing notification following existing regulations.
Compliance Requirements
- Trading members must use the designated security code (KILITCH) for trading
- Trading must be conducted in the specified lot size of 1 share
- Securities are identified by designated codes on the trading system
Important Dates
- Circular effective date: August 28, 2025
- Date of allotment: August 25, 2025
- Trading commencement: August 28, 2025
Impact Assessment
Minimal market impact as this is a routine listing of rights issue shares for a single company. The shares are pari passu with existing equity shares and have no lock-in restrictions. Currently, shares are credited under temporary ISIN in dematerialized mode as per SEBI guidelines for additional issues.
Impact Justification
Routine listing notification for rights issue shares of single company with limited market impact